THE BELGIAN OPHTHALMIC ASSOCIATIONS
AOB SOCIETIES
AOB
BGS
BOG
BOV-ABO
BRS
BSA
BSCRS-BCLSO
BSONT
BSOPRS
COB
OBAO
PEDLOWNOC
SBO
AOB CONGRESSES
AMICO
OB
OTHER SOCIETIES
FRO
SOOS
E-mail:
Retenir mes informations
Besoin d'un nouveau mot de passe? Cliquez ici
Accueil
Congrès
Petites Annonces
Accréditation
Office
Nl
-
Eng
ABOUT BRS
The Belgian Retina Society
Statuts / Publications
Conseil d'Administration
membres fondateurs
MEETINGS
2025 FAB Spring Meeting
2024 FAB Spring Meeting
2024 REBEL Meeting
2025 REBEL Meeting
INFO PAGES
News
Guidelines
RVO guidelines 2024
BRS Guidelines IVT
Treatment Neovascular AMD
Visudyne
Visudyne Application Form
Drug Reimbursement Criteria
Konklijk Besluit/Arrêté Royal
Commercial session by Horus Pharma 2
View entire schedule
Horus Pharma - Optimizing tolerance without compromising efficacy - Belgian experience with a preservative-free latanoprost
Commercial session
Jeudi 23 Novembre 2023, 13:30 - 14:00, SPEAKERS CORNER
Topic
:
Glaucoma
13:30
Optimizing tolerance without compromising efficacy - Belgian experience with a preservative-free latanoprost
COLLIGNON N
top ^